FeesSafety
Pluang+

Amber Group receives 4.669M Ethena tokens worth $1.14M in major crypto transfer

Protocol Fundamentals
06 Oct 2026, 09:03 WIB
Tokenpost
View Source
Bullish
Amber Group receives 4.669M Ethena tokens worth $1.14M in major crypto transfer

Amber Group acquired 4.669 million Ethena (ENA) tokens valued at approximately $1.14 million on October 6. This significant transfer highlights Amber Group's growing involvement in the crypto asset market. The move may indicate strategic positioning or investment in Ethena tokens, reflecting confidence in the asset's potential. Investors should watch for further developments or transactions involving ENA tokens from Amber Group.

Amber Group's acquisition of 4.669 million ENA tokens worth $1.14 million is notable. For readers following cryptocurrency, here is Pluang's market snapshot as of Oct 06, 2026 12:41 WIB: Among 50 major cryptocurrencies, 23 rose and 25 fell. Key movers include CAKE at Rp43.636 with a -3.42% change and 55% sell order activity, XLM at Rp3.865 with a -2.99% change and 72% sell order activity, and CRV at Rp6.648 with a -2.84% change and 87% sell order activity.

More News

Manufacturers expanding Microsoft 365 Copilot must review drawing revisions and supplier permissions to prevent data breaches.

Manufacturers expanding Microsoft 365 Copilot must review drawing revisions and supplier permissions to prevent data breaches.

The 2026 Verizon Data Breach Investigations Report links 61% of manufacturing breaches to third parties and 81% to internal data compromise. Manufacturers adopting Microsoft 365 Copilot should carefully manage which engineering and supplier files emp...

Market News
Neutral
18 minutes ago
Soleo Health chosen as specialty pharmacy partner for new FOP treatment Pasatru™

Soleo Health chosen as specialty pharmacy partner for new FOP treatment Pasatru™

Soleo Health has been selected as a specialty pharmacy partner for Pasatru™ (garetosmab-grts), Regeneron's FDA-approved treatment for adults with fibrodysplasia ossificans progressiva (FOP), an ultra-rare genetic disorder. Pasatru™ is the first treat...

Market News
Bullish
18 minutes ago
PsiThera secures $25M to advance oral immunology drugs targeting TNFα and TL1A pathways.

PsiThera secures $25M to advance oral immunology drugs targeting TNFα and TL1A pathways.

PsiThera raised $25 million in financing led by new investors AbbVie Ventures and Lumination Capital, alongside existing backers. The funds will support development of its oral small molecule TNFα inhibitor and advance its oral TL1A inhibitors into l...

Company Fundamentals
Bullish
18 minutes ago
Opus Genetics reports Q3 2026 results, advances gene therapy trials, and extends cash runway to 2029

Opus Genetics reports Q3 2026 results, advances gene therapy trials, and extends cash runway to 2029

Opus Genetics announced its Q3 2026 financial results and significant progress in its gene therapy programs for inherited retinal diseases. Key milestones include completion of dosing in OPGx-BEST1 Cohort 2 with data expected in Q1 2027, full enrollm...

Company Fundamentals
Bullish
18 minutes ago
Iveco Group showcases new vehicles and tech at Fenatran 2026, boosting Latin America presence.

Iveco Group showcases new vehicles and tech at Fenatran 2026, boosting Latin America presence.

Iveco Group is exhibiting its latest products, including new light and heavy-duty vehicles powered by FPT engines, at Fenatran 2026 in São Paulo, highlighting its strong industrial and commercial presence in Latin America. The event marks the regiona...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App